CTA - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Prilenia Therapeutics to fund late-stage clinical trials in HD and ALS

CTA
So far, the total capital invested in Prilenia since its foundation in September 2018 stands at $84.5m. Credit: Michal Jarmoluk from Pixabay.